Picture of Femasys logo

FEMY Femasys Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Femasys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.91-7.54-11.4-14.2-18.8
Depreciation
Amortisation
Non-Cash Items0.323-0.6250.2310.8371.65
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.558-0.733-0.4581.22-3.14
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-4.93-7.93-10.7-11.3-19.4
Capital Expenditures-0.032-0.307-0.407-0.144-0.848
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items10
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities0.968-0.307-0.407-0.144-0.848
Financing Cash Flow Items-0.075-1.58-0.233-1.3-0.061
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.87229.7-0.68220.22.03
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.0921.5-11.88.75-18.3